Publicaciones (1.097) Publicaciones en las que ha participado algún/a investigador/a

2015

  1. 2014 ESC guidelines on the diagnosis and treatment of aortic diseases

    Russian Journal of Cardiology, Vol. 123, Núm. 7, pp. 7-72

  2. 2014 ESC/ESA guidelines on non-cardiac surgery: Cardiovascular assessment and management

    Russian Journal of Cardiology, Vol. 124, Núm. 8, pp. 7-66

  3. 2014 update on interventional cardiology

    Revista Espanola de Cardiologia, Vol. 68, Núm. 4, pp. 324-330

  4. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases

    European Heart Journal, Vol. 36, Núm. 42, pp. 2921-2964

  5. 2015 ESC Guidelines for the management of infective endocarditis

    European Heart Journal, Vol. 36, Núm. 44, pp. 3075-3123

  6. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC)

    European Heart Journal, Vol. 36, Núm. 41, pp. 2793-2867l

  7. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)

    Europace, Vol. 17, Núm. 11, pp. 1601-1687

  8. 2nd ESMO Consensus Conference in Lung Cancer: Locally advanced stage III non-small-cell lung cancer

    Annals of Oncology, Vol. 26, Núm. 8, pp. 1573-1588

  9. A 50-gene signature is a novel scoring system for tumor-infiltrating immune cells with strong correlation with clinical outcome of stage I/II non-small cell lung cancer

    Clinical and Translational Oncology, Vol. 17, Núm. 4, pp. 330-338

  10. A Phase Ib dose-escalation study of the oral pan-PI3K inhibitor buparlisib (BKM120) in combination with the oral MEK1/2 inhibitor trametinib (GSK1120212) in patients with selected advanced solid tumors

    Clinical Cancer Research, Vol. 21, Núm. 4, pp. 730-738

  11. A Polycomb-mir200 loop regulates clinical outcome in bladder cancer

    Oncotarget, Vol. 6, Núm. 39, pp. 42258-42275

  12. A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with In-Stent Restenosis of Drug-Eluting Stents the RIBS IV Randomized Clinical Trial

    Journal of the American College of Cardiology, Vol. 66, Núm. 1, pp. 23-33

  13. A blood-based, 7-metabolite signature for the early diagnosis of Alzheimer's disease

    Journal of Alzheimer's Disease, Vol. 45, Núm. 4, pp. 1157-1173

  14. A case of thrombotic micro-angiopathy after heart transplantation successfully treated with eculizumab

    Transplant International

  15. A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study

    Microvascular Research, Vol. 102, pp. 19-24

  16. A deletion at adamts9-magi1 locus is associated with psoriatic arthritis risk

    Annals of the Rheumatic Diseases, Vol. 74, Núm. 10, pp. 1875-1881

  17. A european multicentre and open-label controlled randomized trial to evaluate the efficacy of sequential treatment with TAcrolimus-Rituximab versus steroids plus cyclophosphamide in patients with primary MEmbranous Nephropathy: The STARMEN study

    Clinical Kidney Journal, Vol. 8, Núm. 5, pp. 503-510

  18. A founder EIF2AK4 mutation causes an aggressive form of pulmonary arterial hypertension in Iberian Gypsies

    Clinical Genetics, Vol. 88, Núm. 6, pp. 579-583

  19. A genetic study on C5-TRAF1 and progression of joint damage in rheumatoid arthritis

    Arthritis Research and Therapy, Vol. 17, Núm. 1

  20. A gut solution for hepatic encephalopathy

    Hepatology, Vol. 61, Núm. 6, pp. 2107-2009